United States Government Publishing Office publisher pbl distributor dst United States Congress House of Representatives author aut Government Organization text government publication eng BILLS To clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved drug application, and for other purposes.;Over-the-Counter Monograph User Fee Act of 2019;H.R. 3443 (IH) Bills and Statutes 116_cong_bills legislative 2019-06-29 U.S. Government Publishing Office 2019-06-24 monographic deposited born digital 96 p. Y 1.6: Y 1.4/6: P0b002ee1a1995497 https://www.govinfo.gov/app/details/BILLS-116hr3443ih H.R. 3443 021-610-00252-9 000501532 000325573 Congressional bills House bills f:h3443_ih.txt https://www.govinfo.gov/app/details/BILLS-116hr3443ih https://www.govinfo.gov/content/pkg/BILLS-116hr3443ih/html/BILLS-116hr3443ih.htm https://www.govinfo.gov/content/pkg/BILLS-116hr3443ih/pdf/BILLS-116hr3443ih.pdf https://www.govinfo.gov/content/pkg/BILLS-116hr3443ih/xml/BILLS-116hr3443ih.xml fdlp DGPO 2019-06-29 2023-01-02 BILLS-116hr3443ih machine generated eng Diana DeGette United States House of Representatives sponsor spn United States Congress Member Robert E. Latta United States House of Representatives cosponsor United States Congress Member Debbie Dingell United States House of Representatives cosponsor United States Congress Member Brett Guthrie United States House of Representatives cosponsor United States Congress Member United States Congress House of Representatives Committee on Energy and Commerce associated name asn Title 5 Section 552(b)(4) Title 5 Section 553 Title 5 Chapter 5 5 U.S.C. 552(b)(4) 5 U.S.C. 553 5 U.S.C. Chapter 5 Title 18 Section 1905 18 U.S.C. 1905 Title 21 Section 301et seq. Title 21 Section 352 Title 21 Section 355 Title 21 Section 355g Title 21 Section 360fff-3 Title 21 Section 360fff-3(b) Title 21 Section 360fff-3(e) Title 21 Section 360fff-5 Title 21 Section 360fff-6 Title 21 Section 360fff Title 21 Section 360fffet seq. Title 21 Section 379fet seq. Title 21 Section 379r(d)(1) Title 21 Section 381(e)(4)(E)(iii) 21 U.S.C. 301et seq. 21 U.S.C. 352 21 U.S.C. 355 21 U.S.C. 355g 21 U.S.C. 360fff-3 21 U.S.C. 360fff-3(b) 21 U.S.C. 360fff-3(e) 21 U.S.C. 360fff-5 21 U.S.C. 360fff-6 21 U.S.C. 360fff 21 U.S.C. 360fffet seq. 21 U.S.C. 379fet seq. 21 U.S.C. 379r(d)(1) 21 U.S.C. 381(e)(4)(E)(iii) Title 31 Chapter 37 31 U.S.C. Chapter 37 Title 44 Chapter 35 44 U.S.C. Chapter 35 Public Law 115-52 hr BILLS-116hr3443ih 116 1 HOUSE HOUSE 3443 ih ih Over-the-Counter Monograph User Fee Act of 2019 To clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved drug application, and for other purposes. Ms. DeGette (for herself, Mr. Latta, Mrs. Dingell, and Mr. Guthrie) introduced the following bill; which was referred to the Committee on Energy and Commerce Committee on Energy and Commerce Energy and Commerce Ms. DeGette Diana DeGette DeGette, Diana Mr. Latta Robert E. Latta Latta, Robert E. Mr. Robert Latta Mrs. Dingell Debbie Dingell Dingell, Debbie Mr. Guthrie Brett Guthrie Guthrie, Brett false false